pH Dependence of Mitomycin C-induced Cross-Linking Activity in EMT6 Tumor Cells

Cancer Research

Volumn 45, Issue 8, 1985, Pages 3541-3547

  Kennedy, Katherine A ^a   McGurl, John D ^a   Leondaridis, Leonidas ^a   Alabaster, Oliver ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; RADIOISOTOPE;

CANCER CELL CULTURE; DNA CROSS LINKING; DRUG EFFICACY; ELUTION; FLOW CYTOMETRY; IN VITRO STUDY; NONHUMAN; PH; PRIORITY JOURNAL; THYMIDINE C 14; THYMIDINE H 3; TUMOR CELL;

ANIMAL; AZIRIDINES; BIOTRANSFORMATION; BUFFERS; CELL LINE; CROSS-LINKING REAGENTS; DNA, NEOPLASM; HYDROGEN-ION CONCENTRATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MITOMYCIN; MITOMYCINS; NADPH-FERRIHEMOPROTEIN REDUCTASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022007423     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Crooke, S. T., and Bradner, W. T. Mitomycin C: a review. Cancer Treat. Rep., 3; 121–139,1976.
2. Iyer, V. N., and Szybalski, W. A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proc. Natl. Sci. USA, 50: 355–362, 1963.
3. Iyer, V. N., and Szybalski, W. Mitomycins and porfiromycin: chemical mechanisms of activation and crossLInking of DNA, Science (Wash. DC), 145:55–58, 1964.
4. Lown, J. W., Begleiter, A., Johnson, D., and Morgan. A. R. Studies related to antitumor antibiotics V. Reaction of mitomycin C with DNA examined by ethidium fluorescence assay. Can. J. BiochemM 54:110–119,1976.
5. Handa, K., and Sato, S. Generation of free radicals of quinone group containing anticancer chemicals in NADPH-rnicrosorne system as evidenced by initiation of sulfite oxidation. Gann, 66:43–47,1975.
6. Bachur, N., Gordon, S., and Gee, M. V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res., 38: 1745–1750.1978.
7. Bachur, N., Gordon, S., Gee, M. V., and Kon, H. NADPH-cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA, 76: 954–957,1979.
8. Tomasz, M. H2O2generation during the redox cycle of mitomycin C and DNA bound mitomycin C. Chem.-Biol. Interact., 73: 89–97,1976.
9. Trush, M. A., Mimnaugh, E. G., Ginsberg, E., and Gram, T. E. Studies on the in vitro interaction of mitomycin C, nitrofurantoin and paraquat with pulmonary microsomes. Stimulation of reactive oxygen-dependent lipid peroxidation. Biochem. Pharmacol., 37:805–814,1982.
10. Schwartz, H. S. Pharmacology of mitomycin C III. In vitro metabolism by rat liver. J. Pharmacol. Exp. Ther., 736; 250–258,1962.
11. Schwartz, H. S., Sodergren, J., and Phillips, F. S. Mitomycin C: chemical and biological studies on alkylation. Science (Wash. DC), 742; 1181–1183,1963.
12. Kennedy, K. A., Rockwell, S., and Sartorelli, A. C. Preferential activation by mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res., 40: 2356–2360.1980.
13. Kennedy. K. A., Sligar, S. G., Polomski, L., and Sartorelli, A. C. Metabolic activation of mitomycin C by liver microsomes and nuclei. Biochem. Pharmacol. 37:2011–2016,1982.
14. Fracasso, P. M. Mitomycin C and porfiromycin: studies on bioactivation and cytotoxicity in cultured cell lines. Ph.D. Dissertation, Yale University, 1984.
15. Keyes, S. R., Fracasso. P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. Role of NADPH-cytochrome c reductase and DT diaphor-ase in the biotransformation of mitomycin C. Cancer Res., 44: 5638–5643, 1984.
16. Tomasz, M., and Lipman, R. Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry, 20; 5056–5061, 1981.
17. Komiyama, T., Oki, T., and Inui, T. Activation of mitomycin C and quinone drug metabolism by NADPH-cytochrome P-450 reductase. J. Pharmacobio-Dyn., 2: 407–410.1979.
18. Pan. S. S., Andrews, P. A., Glover, C. J., and Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem., 259:959–966,1984.
19. Tomasz, M., Mercade, C. M., Olson, J., and Chatterjie, N. The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. Biochemistry, 73; 4878–4887,1974.
20. Tomasz, M., and Lipman, R. Alkylation reactions of mitomycin C at acid pH. J. Am. Chem. Soc., 707:6063–6067,1979.
21. Lown, J. W., and Weir, G. Studies related to antitumor antibiotics. Part XIV: reactions of mitomycin B with DNA. Can. J. Biochem., 56:296–304,1978.
22. Underberg, W. J. M., and Ungeman, H. Aspects of the chemical stability of mitomycin and porfiromycin in acidic solution. J. Pharm. Sci., 72: 549–553, 1983.
23. Rockwell, S. In vivo-in vitro tumor systems: new models for studying the response to tumors to therapy. Lab. Anim. Sci., 27 (Part 2): 831–851.1977.
24. Kohn, K. W. DNA as a target in cancer chemotherapy: measurement of macromolecular damage produced in mammalian cells by anticancer drugs and carcinogens. Methods Cancer Res., 16A 291–345,1979.
25. Zwelling, L. A., Michaels, S., Schwartz, H., Dobson, P. P., and Kohn, K. W. DNA crosslinking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichlorplatinum and L-phenylalanine mustard. Cancer Res., 41:640–649,1981.
26. Valet, G., Raffael, A., Moroder, L., Wunsch, E., and Ruhenstroth-Bauer. G. Fast intracellular pH determination in single cells by flow cytometry. Naturwis-senschaften, 68: S265,1981.
27. Alabaster, O., Carr, K. C. and Leondaridis. L. Tumor cell heterogeneity: its determination by flow cytometric analysis of intracellular pH. Methods Achiev. Exp. Pathol., 77: 96–110,1984.
28. Alabaster. O., Andreef, M., Spooner. C. and Qagett. K. Flow cytometric measurement of intracellular pH: a dosimetric approach to metabolic heterogeneity. In: W. G. Eisert and M. L. Mendelsohn (eds.). Biological Dosimetry, pp. 299–309. Berlin: Springer-Verlag, 1984.
29. Steele, R. G. D., and Tome, J. H. Principles and Procedures of Statistics, pp. 99–112. New York: McGraw-Hill Book Co., 1960.
30. Goldie, J. H., and Coldman, A. J. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res., 44: 3643–3653, 1984.
31. Heppner, G. Tumor heterogeneity. Cancer Res., 44:2259–2265,1984.
32. Kennedy, K. A., Teicher, B. A., Rockwell, S., and Sartorelli, A. C. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem. Pharmacol., 29:1–8,1980.
33. Kennedy, K. A., Teicher, B. A., Rockwell, S., and Sartorelli, A. C. Chemother-apeutic approaches to cell populations of tumors. In: A. C. Sartorelli, J. R. Bertino, and J. S. Lazo (eds.), Molecular Targets and Actions for Cancer Chemotherapeutic Agents, pp. 85–101. Mew York: Academic Press, Inc., 1981.
34. Guillino, P. M. In vivo utilization of oxygen and glucose by neoplastic tissue. Adv. Exp. Med. Biol., 75: 521–536,1975.
35. Vaupel, P. W., Frinak, S., and Bicher, H. I. Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary aderwcarcinoma. Cancer Res., 41: 2008–2013,1981.
36. GuiHino, P. M., Grantham, F. H., Smith, S. H., and Haggerty, A. C. Modifications of the acid-base status of the internal milieu of tumors. J. Natl. Cancer Inst., 34: 857–869.1965.
37. Ceccarini, C., and Eagle, H. pH as a determinant of cellular growth and contact inhibition. Proc. Natl. Acad. Sci. USA. 68:229–233.1971.
38. Taylor, I. W., and Hodson, P. J. Cell cycle regulation by environmental pH. J. Cellular Physiol., 121: 517–525,1984.
39. Moolenaar, W. H., Tertooten, L. G. J., and DeLaat, S. W. Phorbol ester and diacylgtycerol mimic growth factors in raising cytoplasmic pH. Nature (Lond.), 372; 371–374,1984.
40. Hesketh, T. R., Moore, J. P., Morris, J. D. H., Taylor, M. V., Roger, J., Smith, G. A., and Metcalfe, J. C. A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells. Nature (Lond.), 373; 481–484, 1985.
41. Keyes, S. R., Heimbrook, D. C., Fracasso, P. M., Rockwell, S., Sligar, S. G., and Sartorei, A. C. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin. Adv. Enzyme Regulat., in press, 1985.
42. Strobe!, H. W., and Dignan, J. D., Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol., 52:89–96,1978.
43. Williams, Jr., C. H. Thioredoxin reductase. Enzymes, 73; 142–148,1976.
44. Szmigiero, L., and Kohn, K. W. Mechanisms of DNA strand breakage and interstrand cross-linking of diaziridinylbenzoquinone (diaziquon) in isolated nuclei from human cells. Cancer Res., 44:4453–4457,1984.
45. King, C. L., Wong, S. K., and Loo, T. L. Alkylation of DNA by the new anticancer agent 3,6-tfaziridinyl-2,5-bis(carboethoxyam,4-benzoquinone (AZQ). Eur. J. Clin. Oncol., 20:261–264,1984.
46. King, C. L., Hrtteknan, W. N., and Loo, T. L. Induction of DNA strand breaks and crosslinks by 2,5-oiaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary ceNs. Cancer Res., 44:5634–5637,1984.